France, Oct. 14 -- France based OSIVAX has secured contract from Health And Human Services, Department Of for Clinical Proof Of Concept Of Ovx836, A Single-Shot Broadly Protective Influenza A Vaccine For Immediate Protection Against Emerging Pandemic Strains. The value of the contract is worth 98593151 USD.
Published by HT Digital Content Services with permission from Pivotal Sources....